QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)

Chemours - CC Stock Forecast, Price & News

$30.89
+0.14 (+0.46%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$30.40
$31.29
50-Day Range
$24.10
$33.68
52-Week Range
$22.56
$44.95
Volume
1.16 million shs
Average Volume
1.69 million shs
Market Capitalization
$4.66 billion
P/E Ratio
5.51
Dividend Yield
3.25%
Price Target
$33.00

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.10 Rating Score
Upside/​Downside
6.8% Upside
$33.00 Price Target
Short Interest
Healthy
3.40% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.16mentions of Chemours in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-5.94%
From $4.88 to $4.59 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Basic Materials Sector

66th out of 163 stocks

Chemicals & Allied Products Industry

7th out of 15 stocks

CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

Chemours (NYSE:CC) Trading Down 3.9%
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
When Should You Buy The Chemours Company (NYSE:CC)?
Chemours (NYSE:CC) Is Due To Pay A Dividend Of $0.25
Chemours (CC) Q3 2022 Earnings Call Transcript
Chemours (CC) Surpasses Q3 Earnings and Revenue Estimates
The Chemours Company Reports Third Quarter 2022 Results
Should You Consider to Sell The Chemours Company (CC)?
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Ex-Dividend for 9/15 Dividend
8/12/2022
Dividend Payable
9/15/2022
Last Earnings
10/25/2022
Ex-Dividend for 12/15 Dividend
11/14/2022
Today
12/06/2022
Dividend Payable
12/15/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/09/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$33.00
High Stock Price Forecast
$41.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
+6.8%
Consensus Rating
Hold
Rating Score (0-4)
2.10
Research Coverage
10 Analysts

Profitability

Net Income
$608 million
Pretax Margin
15.79%

Debt

Sales & Book Value

Annual Sales
$6.35 billion
Cash Flow
$6.05 per share
Book Value
$6.64 per share

Miscellaneous

Free Float
146,330,000
Market Cap
$4.66 billion
Optionable
Optionable
Beta
1.88

Key Executives

  • Mr. Mark E. NewmanMr. Mark E. Newman (Age 59)
    CEO, Pres & Director
    Comp: $2.5M
  • Mr. Sameer RalhanMr. Sameer Ralhan (Age 48)
    Sr. VP & CFO
    Comp: $1.55M
  • Ms. Susan M. Kelliher (Age 55)
    Sr. VP of People
    Comp: $955.72k
  • Mr. Edwin C. SparksMr. Edwin C. Sparks (Age 48)
    Pres of Titanium Technologies & Chemical Solutions
    Comp: $1.32M
  • Ms. Camela T. Wisel (Age 47)
    VP, Chief Accounting Officer & Controller
  • Kurt Bonner
    Mang. of Investor Relations
  • Ms. Kristine Wellman
    Sr. VP, Gen. Counsel & Company Sec.
  • Ms. Alvenia ScarboroughMs. Alvenia Scarborough (Age 48)
    Sr. VP of Corp. Communications & Chief Brand Officer
  • Ms. Alisha BellezzaMs. Alisha Bellezza (Age 46)
    Pres of Thermal & Specialized Solutions
  • Mr. Jonathan S. Lock (Age 41)
    Section 16 Officer, Sr. VP & Chief Devel. Officer













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2023?

10 Wall Street research analysts have issued twelve-month price targets for Chemours' shares. Their CC share price forecasts range from $24.00 to $41.00. On average, they anticipate the company's stock price to reach $33.00 in the next year. This suggests a possible upside of 7.1% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2022?

Chemours' stock was trading at $33.56 on January 1st, 2022. Since then, CC stock has decreased by 8.2% and is now trading at $30.80.
View the best growth stocks for 2022 here
.

Are investors shorting Chemours?

Chemours saw a increase in short interest in November. As of November 15th, there was short interest totaling 5,050,000 shares, an increase of 5.9% from the October 31st total of 4,770,000 shares. Based on an average daily volume of 1,710,000 shares, the short-interest ratio is presently 3.0 days. Currently, 3.4% of the shares of the stock are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its earnings results on Tuesday, October, 25th. The specialty chemicals company reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $1.16 by $0.08. The specialty chemicals company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.67 billion. Chemours had a trailing twelve-month return on equity of 73.45% and a net margin of 12.91%. Chemours's quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.27 EPS.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Tuesday, October 25th. Investors of record on Tuesday, November 15th will be paid a dividend of $0.25 per share on Thursday, December 15th. This represents a $1.00 annualized dividend and a dividend yield of 3.25%. The ex-dividend date of this dividend is Monday, November 14th.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.19%. The dividend payout ratio is 17.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 21.79% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CC.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (11.92%), Vanguard Group Inc. (11.76%), State Street Corp (3.00%), LSV Asset Management (2.06%), Dimensional Fund Advisors LP (1.48%) and Bank of New York Mellon Corp (1.47%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Richard H Brown and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $30.80.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $4.65 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $5.61 on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,400 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 12/6/2022 by MarketBeat.com Staff